Clinical Report: Profiles of Soluble IL-2 Receptor and Memory Treg in RA
Overview
This study identifies distinct immune profiles that differentiate treatment-naïve rheumatoid arthritis (TN-RA) from undifferentiated arthritis (UA) at initial presentation. An eight-feature immune signature, including soluble IL-2 receptor (sIL-2R) and memory Tregs, demonstrates high accuracy in classification.
Background
Rheumatoid arthritis (RA) poses significant diagnostic challenges, particularly in early stages where patients may not meet established classification criteria. Identifying biomarkers that can distinguish TN-RA from UA is crucial for timely intervention and management. The study explores the role of immune profiling in enhancing diagnostic accuracy for early inflammatory arthritis.
Th17/Treg imbalance, preserved Th2 and Th17 responses
Key Findings
Distinct immune profiles were identified between TN-RA and UA at initial presentation.
TN-RA showed IL-2 signaling exhaustion and systemic inflammation.
UA exhibited a Th17/Treg imbalance with preserved Th2 and Th17 responses.
An eight-feature immune signature discriminated TN-RA from UA with an AUC of 0.959.
sIL-2R and IL-6 were the strongest contributors to the immune signature.
Clinical Implications
The findings suggest that immune profiling, particularly through the assessment of sIL-2R and memory Tregs, may enhance diagnostic accuracy for early RA. This could inform clinical decision-making when conventional classification criteria are insufficient.
Conclusion
The study highlights the potential of an immune-based classifier to distinguish TN-RA from UA, emphasizing the importance of the IL-2-Treg axis in early rheumatoid arthritis diagnosis.
